Longitudinal Tumor Microenvironment Analysis in Extensive Stage SCLC Patients Treated with Dual Checkpoint Inhibitor Blockade

被引：0
|
作者：
Chiang, A. [1 ]
Matera, R. [1 ]
Ashley, K. [2 ]
Rajendran, B. K. [2 ]
Schalper, K. A. [2 ]
机构：
[1] Yale Univ, Sch Med, New Haven, CT USA
[2] Yale Univ, New Haven, CT USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2024年 / 19卷 / 10期
关键词：
SCLC; Tumor Microenvironment; immunotherapy;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3.13D.07
引用
收藏
页码：S362 / S362
页数：1
相关论文
共 50 条
  • [1] The Tumor Immune Microenvironment and Frameshift Neoantigen Load Determine Response to PD-L1 Blockade in Extensive-Stage SCLC
    Kanemura, Hiroaki
    Hayashi, Hidetoshi
    Tomida, Shuta
    Tanizaki, Junko
    Suzuki, Shinichiro
    Kawanaka, Yusuke
    Tsuya, Asuka
    Fukuda, Yasushi
    Kaneda, Hiroyasu
    Kudo, Keita
    Takahama, Takayuki
    Imai, Ryosuke
    Haratani, Koji
    Chiba, Yasutaka
    Otani, Tomoyuki
    Ito, Akihiko
    Sakai, Kazuko
    Nishio, Kazuto
    Nakagawa, Kazuhiko
    JTO CLINICAL AND RESEARCH REPORTS, 2022, 3 (08):
  • [2] Molecular predictors and immunomodulatory role of dual checkpoint inhibitor blockade using ipilimumab/nivolumab in patients with extensive stage small cell lung cancer
    Chiang, Anne C.
    Asghari, Hossein
    Ashley, Kerryan
    Gettinger, Scott N.
    Goldberg, Sarah B.
    Herbst, Roy S.
    Wilson, Frederick Hugh
    Newton, Benjamin Robert
    Cohenuram, Michael Keith
    Sabbath, Kert D.
    Talsania, Ashita D.
    Russo, Armand Vincent
    Schultz, Eric
    Skrzypczak, Stan
    Kingsford, Carl
    Schalper, Kurt A.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [3] Synchronous Oligometastasis and Oligoprogression as a Prognostic Marker in Patients With Extensive-Stage SCLC Treated With a Combination of Immune-Checkpoint Inhibitor and Chemotherapy (HOT2301)
    Hashimoto, Kana
    Morinaga, Daisuke
    Asahina, Hajime
    Ishidoya, Mina
    Kikuchi, Hajime
    Yokouchi, Hiroshi
    Harada, Toshiyuki
    Honjo, Osamu
    Shigaki, Ryota
    Takashina, Taichi
    Fujita, Yuka
    Takahashi, Mamoru
    Kawai, Yasutaka
    Kida, Ryotaro
    Ito, Kenichiro
    Sukoh, Noriaki
    Takahashi, Ayumu
    Hommura, Fumihiro
    Ohhara, Yoshihito
    Furuta, Megumi
    Konno, Satoshi
    Hosomi, Yukio
    Oizumi, Satoshi
    JTO CLINICAL AND RESEARCH REPORTS, 2024, 5 (11):
  • [4] Longitudinal Imaging Studies of Tumor Microenvironment in Mice Treated with the mTOR Inhibitor Rapamycin
    Saito, Keita
    Matsumoto, Shingo
    Yasui, Hironobu
    Devasahayam, Nallathamby
    Subramanian, Sankaran
    Munasinghe, Jeeva P.
    Patel, Vyomesh
    Gutkind, J. Silvio
    Mitchell, James B.
    Krishna, Murali C.
    PLOS ONE, 2012, 7 (11):
  • [5] Unleashing the potential of combining FGFR inhibitor and immune checkpoint blockade for FGF/FGFR signaling in tumor microenvironment
    Ruan, Ruiwen
    Li, Li
    Li, Xuan
    Huang, Chunye
    Zhang, Zhanmin
    Zhong, Hongguang
    Zeng, Shaocheng
    Shi, Qianqian
    Xia, Yang
    Zeng, Qinru
    Wen, Qin
    Chen, Jingyi
    Dai, Xiaofeng
    Xiong, Jianping
    Xiang, Xiaojun
    Lei, Wan
    Deng, Jun
    MOLECULAR CANCER, 2023, 22 (01)
  • [6] Unleashing the potential of combining FGFR inhibitor and immune checkpoint blockade for FGF/FGFR signaling in tumor microenvironment
    Ruiwen Ruan
    Li Li
    Xuan Li
    Chunye Huang
    Zhanmin Zhang
    Hongguang Zhong
    Shaocheng Zeng
    Qianqian Shi
    Yang Xia
    Qinru Zeng
    Qin Wen
    Jingyi Chen
    Xiaofeng Dai
    Jianping Xiong
    Xiaojun Xiang
    Wan Lei
    Jun Deng
    Molecular Cancer, 22
  • [7] Mechanisms of tumor response and resistance to radiation and dual checkpoint blockade in mice and patients
    Victor, Christina Twyman-Saint
    Rech, Andrew
    Maity, Amit
    Rengar, Ramesh
    Pauken, Kristen
    Stelekati, Erietta
    Benci, Joseph
    Xu, Bihui
    Dada, Hannah
    Odorizzi, Pamela
    Herati, Ramin
    Mansfield, Kathleen
    Patsch, Dana
    Amaravadi, Ravi
    Schuchter, Lynn
    Ishwaran, Hemant
    Mick, Rosemarie
    Pryma, Daniel
    Xu, Xiaowei
    Feldman, Michael
    Gangadhar, Tara
    Hahn, Stephen
    Wherry, E. John
    Vonderheide, Robert
    Minn, Andy
    CANCER IMMUNOLOGY RESEARCH, 2016, 4 (01)
  • [8] Mechanisms of tumor response and resistance to radiation and dual checkpoint blockade in mice and patients
    Twyman-Saint Victor, Christina
    Rech, Andrew
    Benci, Joseph
    Maity, Amit
    Rengan, Ramesh
    Pauken, Kristen
    Stelekati, Erietta
    Xu, Bihui
    Dada, Hannah
    Odorizzi, Pamela
    Herati, Ramin
    Amaravadi, Ravi
    Schuchter, Lynn
    Ishwaran, Hemant
    Mick, Rosemarie
    Pryma, Daniel
    Xu, Xiaowei
    Feldman, Michael
    Gangadhar, Tara
    Hahn, Steve
    Wherry, John
    Vonderheide, Robert
    Minn, Andy
    CANCER RESEARCH, 2016, 76
  • [9] Impact of baseline characteristics on extensive-stage SCLC patients treated with etoposide/carboplatin: A secondary analysis of a phase III study
    Abdel-Rahman, Omar
    CLINICAL RESPIRATORY JOURNAL, 2018, 12 (10): : 2519 - 2524
  • [10] Analysis of Tumor Microenvironment Characteristics in Bladder Cancer: Implications for Immune Checkpoint Inhibitor Therapy
    Chen, Xingyu
    Chen, Haotian
    He, Dong
    Cheng, Yaxin
    Zhu, Yuxing
    Xiao, Mengqing
    Lan, Hua
    Wang, Zhanwang
    Cao, Ke
    FRONTIERS IN IMMUNOLOGY, 2021, 12
12345